from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0918/-

LFCtreatmentdescriptionclass of inhibitor

-0.060

Amikacinug/mL Amikacintranslation

-0.960

Cap5-10ug/mL Capreomycintranslation

0.173

Rox10-50 ug/mL Roxithromycintranslation

-1.128

SM2-5 ug/mL Streptomycintranslation

0.425

Tet5-10 ug/mL Tetracyclinetranslation

1.156

Rif0.2-5ug/mL Rifampicintranscription

0.288

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.499

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.534

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.172

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.511

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.805

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.283

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.210

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.080

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.316

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.077

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.303

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.259

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.524

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.897

Nigericin50 uM Nigericinrespiration

0.331

TRC10-150 ug/mL Triclosanrespiration

-0.124

TRZ10-25 ug/mL Thioridazinerespiration

-0.197

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.980

menadione6-10 ug/mL Menadionerespiration

0.104

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.083

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.126

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.617

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.405

NRP_1Non-replicating persistence stage 1dosRassociated

-0.817

Amp0.2mg/mL AmpicillincellWall

0.265

Cephalexin20-100 ug/mL CephalexincellWall

1.093

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.229

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.380

EMB10-20 ug/mL EthambutolcellWall

-0.689

Eta12-40 ug/mL EthionamidecellWall

-0.638

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.504

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.097

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.640

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.314

BZA0.12 mg/mL BenzamidearomaticAmides

0.660

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.383

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.054

H2O24 mM hydrogen peroxideDNAdamaging

0.077

Levo10 ug/mL LevofloxacinDNAdamaging

0.423

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.020

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.553

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.345

UVUV-irradiationDNAdamaging

-1.193

ARP41-4 ug/mL Antitubercular compound ARP4?

0.267

Antimycin12.5-50 ug/mL Antimycin A?

-0.997

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.095

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.494

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.528

PA8240.2-2 ug/mL PA-824?

-0.575

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.572

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.223

Verapamil50 uM Verapamil?

-1.525

mercaptoethanol2 mM 2-Mercaptoethanol?

0.056

methoxatin10-20 ug/mL Methoxatin?